Incorporation of the TLR4 Agonist Monophosphoryl Lipid A Into the Bilayer of DDA/TDB Liposomes: Physico-Chemical Characterization and Induction of CD8+ T-Cell Responses In Vivo (Q58827790)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Incorporation of the TLR4 Agonist Monophosphoryl Lipid A Into the Bilayer of DDA/TDB Liposomes: Physico-Chemical Characterization and Induction of CD8+ T-Cell Responses In Vivo	article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Incorporation of the TLR4 agonist monophosphoryl lipid A into the bilayer of DDA/TDB liposomes: physico-chemical characterization and induction of CD8+ T-cell responses in vivo (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

toll-like receptor

0 references

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Else Marie Agger

2

object named as

Else Marie Agger

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Pernille Nordly

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hanne Mørck Nielsen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

2 November 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Pharmaceutical Research

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

553-562

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

The perfect mix: recent progress in adjuvant research

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

The path to a successful vaccine adjuvant--'the long and winding road'.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Bridging the knowledge gaps in vaccine design

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Targeting the innate immune response with improved vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Recent advances in the discovery and delivery of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

A potent adjuvant monophosphoryl lipid A triggers various immune responses, but not secretion of IL-1beta or activation of caspase-1.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Host factors impacting the innate response in humans to the candidate adjuvants RC529 and monophosphoryl lipid A.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Enhancement of antigen-specific immunity via the TLR4 ligands MPL adjuvant and Ribi.529.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Determining Adjuvant Activity on T-Cell Function In Vivo: Th Cells

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Trehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-drying

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

A comparative study of cationic liposome and niosome-based adjuvant systems for protein subunit vaccines: characterisation, environmental scanning electron microscopy and immunisation studies in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-010-0301-9

21 January 2018

Delivery by Cationic Gelatin Nanoparticles Strongly Increases the Immunostimulatory Effects of CpG Oligonucleotides

1 reference

https://pubmed.ncbi.nlm.nih.gov/21042837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Well-defined and potent liposomal meningococcal B vaccines adjuvated with LPS derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/21042837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of fine structure of lipid A on Limulus amebocyte lysate clotting and toxic activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/21042837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/21042837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/beta

1 reference

https://pubmed.ncbi.nlm.nih.gov/21042837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21042837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/21042837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of a nontoxic monophosphoryl lipid A.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21042837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11095-010-0301-9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21042837%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58827790&oldid=1767426729"